Emerald Health Therapeutics, Inc. (CVE:EMH – Get Free Report) shares traded down 3.8% during mid-day trading on Wednesday . The company traded as low as C$0.25 and last traded at C$0.26. 384,329 shares changed hands during mid-day trading, a decline of 40% from the average session volume of 644,760 shares. The stock had previously closed at C$0.27.
Emerald Health Therapeutics Stock Down 3.8 %
The business has a 50 day simple moving average of C$0.26 and a 200-day simple moving average of C$0.26. The company has a debt-to-equity ratio of 35.45, a quick ratio of 2.61 and a current ratio of 2.97. The firm has a market capitalization of C$52.28 million and a price-to-earnings ratio of -0.37.
About Emerald Health Therapeutics
Emerald Health Therapeutics, Inc, together with its subsidiaries, produces and sells medical cannabis for medical purpose in Canada. The company is also involved in developing natural health products. It offers dried cannabis strains, pre-rolls, and cannabis oil products to its medical patients. The company was formerly known as T-Bird Pharma Inc and changed its name to Emerald Health Therapeutics, Inc in June 2015.
Featured Stories
- Five stocks we like better than Emerald Health Therapeutics
- Bank Stocks – Best Bank Stocks to Invest In
- How Much Can You Make in Stocks in One Month?
- Buy P&G Now, Before It Sets A New All-Time High
- This Is the Top Large-Cap Stock Insiders Are Buying
- Investing in Construction Stocks
- Capitalize on Micron’s 24% Drop—Wall Street Eyes Major Upside
Receive News & Ratings for Emerald Health Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Emerald Health Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
